Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xanthines--symptomatic or prophylactic in asthma?

C G Persson1, I Erjefält, B Gustafsson

  • 1Pharmacological Laboratory, AB Draco, Lund, Sweden.

Agents and Actions. Supplements
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of epicardial adipose tissue thickness and cardiac structure and function in early midlife - The cardiovascular risks in Young Finns Study.

European journal of preventive cardiology·2025
Same author

Fueling of a marine-terrestrial ecosystem by a major seabird colony.

Scientific reports·2020
Same author

Virome definition in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2018
Same author

Music therapy supported the health-related quality of life for children undergoing haematopoietic stem cell transplants.

Acta paediatrica (Oslo, Norway : 1992)·2018
Same author

Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia.

British journal of cancer·2016
Same author

Music therapy can lower the heart rates of severely sick children.

Acta paediatrica (Oslo, Norway : 1992)·2016
Same journal

Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.

Agents and actions. Supplements·1998
Same journal

Immunomodulation of Crohn's disease by interleukin-10.

Agents and actions. Supplements·1998
Same journal

Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.

Agents and actions. Supplements·1998
Same journal

Symposium new drugs for inflammatory, allergic and immunologic disease.

Agents and actions. Supplements·1998
Same journal

The complexity of the B7-CD28/CTLA-4 costimulatory pathway.

Agents and actions. Supplements·1998
Same journal

A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.

Agents and actions. Supplements·1998
See all related articles

Xanthines may be more effective for asthma and COPD as anti-inflammatory agents rather than bronchodilators. Their benefits stem from reducing airway inflammation and stabilizing cellular functions, offering prophylactic rather than symptomatic relief.

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Immunology

Background:

  • Xanthines are traditionally classified as bronchodilators.
  • Their clinical efficacy in asthma and COPD is debated, with potential anti-inflammatory roles.
  • Understanding the precise mechanisms of xanthines in airway inflammation is crucial.

Purpose of the Study:

  • To re-evaluate the classification of xanthines based on their mechanism of action.
  • To investigate the anti-inflammatory effects of xanthines in airway diseases.
  • To explore the potential of novel xanthines like enprofylline.

Main Methods:

  • Review of existing literature on xanthine pharmacology and clinical effects.
  • Analysis of xanthine's impact on immediate and late-phase bronchoconstriction.

Related Experiment Videos

  • Assessment of xanthine's effects on inflammatory cells and airway barrier functions.

    • Main Results:

    • Xanthines show limited efficacy against immediate bronchoconstriction but inhibit late-phase reactions.
    • Anti-inflammatory effects include stabilizing inflammatory cells and T-lymphocytes.
    • Xanthines stabilize airway epithelium and microvessel walls, reducing mediator release and plasma exudation.
    • Enprofylline demonstrates potent antiasthma effects without theophylline-like side effects.

    Conclusions:

    • Xanthines' primary benefit in asthma and COPD may be their anti-inflammatory action, not bronchodilation.
    • They act prophylactically by modulating inflammatory pathways and stabilizing airway structures.
    • Further research into xanthine mechanisms could lead to improved therapeutic strategies for airway diseases.